Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2026 Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2026 Earnings Call Transcript May 5, 2026Supernus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.602, expectations were $0.28.



